Please assess the completion status of the following clinical trial:

Trial Title: Clinical Estradiol Trial in Women With Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Female patients of potential child-bearing age (Pre-menopausal and Post-menarche)~* Female patients who have a current diagnosis of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder (not in manic phase)~* Female patients who score more than or equal to 60 on PANSS rating scale~* Female patients who are able to give informed consent~Exclusion Criteria:~* Female patients who are pregnant or lactating.~* Female patients with known severe abnormalities in the hypothalamo-pituitary gonadal axis, thyroid dysfunction, central nervous system tumours, or other serious medical conditions which would contraindicate estrogen use.~* Female patients already taking estrogen preparations such as the oral contraceptive pill~* Post-menopausal or pre-menarche female patients.~* Female patients whose psychotic illness is due to illicit drugs or who have a history of consistent substance abuse or dependence during the last 6 months.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).